D. Moradpour

Discipline

Psychology (7) Biological anthropology (4) Political science (3) Economies and finances (3) Sociology (1) Communication sciences (1) Management (1) Geography (1) Architecture, space management (1)

Type

Articles (82) Reviews (20) Conferences and symposiums (3)

Co-author

Date

Source

Keyword

Patients (42) Patients (39) Liver (38) Human beings (35) Treatment (34) Infection (28) infection (27) disease (25) disease (25) Hepatitis C virus (23) Hepatitis (22) virus (21) Hepatitis C (20) Therapeutics (18) RNA (18) therapy (16) well (15) Hepatitis E (14) risk (13) analysis (13) adult (13) Development (13) Risk (13) Analysis (13) Transplantation (13) adult (13) protein (12) age (11) Liver--Cancer (11) Expression (11)

Documents written by D. Moradpour (85) | is about D. Moradpour (0)

Cancer du pancréas : une épidémie oncologique en devenir ?
J.L. Frossard et al. (Aug 28, 2024)
Maladie hépatique associée à la chirurgie de Fontan [Fontan associated liver disease]
T. Shams et al. (Aug 28, 2024)
High prevalence of short telomeres in idiopathic porto-sinusoidal vascular disorder.
A. Coukos et al. (Aug 1, 2024)
Direct oral anticoagulants in cirrhosis: Rationale and current evidence.
C. Pereira Portela et al.
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.
E. Moschouri et al. (Jun 24, 2024)
Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.
Z.M. Xu et al. (Jun 6, 2024)
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E.
A. Saadat et al. (Jun 1, 2024)
Elevated liver function tests in a patient with breast cancer.
C. Neftel et al.
Traitements à siRNA : état des lieux et perspectives [siRNA therapeutics : Current options and perspectives]
C. Neftel et al. (Aug 30, 2023)
Body composition and short-term mortality in patients critically ill with acute-on-chronic liver failure.
T. Mangana Del Rio et al.
Expanding the Hepatitis E Virus Toolbox: Selectable Replicons and Recombinant Reporter Genomes.
N. Oechslin et al. (Mar 28, 2023)
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
A. Coukos et al.
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]
A. Coukos et al. (Aug 31, 2022)
La résection endoscopique va-t-elle suppléer la chirugie ?
J.L. Frossard et al. (Aug 31, 2022)
Métabolisme et suivi thérapeutique de l’azathioprine en gastroentérologie et hépatologie [Metabolism and therapeutic monitoring of azathioprine in gastroenterology and hepatology]
D. Bianchetti et al. (Aug 31, 2022)
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction.
F. Artru et al.
Development of an assay by liquid chromatography coupled to tandem mass spectrometry for thiopurines drugs in whole blood and application for their Therapeutic Drug Monitoring
N. Nguyen et al. (Jun 1, 2022)
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
J. Herderschee et al.
Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis.
S. Kasmi et al. (Feb 28, 2022)
Hepatitis E virus RNA-dependent RNA polymerase is involved in RNA replication and infectious particle production.
N. Oechslin et al.
Impact du Covid-19 sur la gastroentérologie et l’hépatologie.
A. Schoepfer et al. (Sep 1, 2021)
Hépatite autoimmune : mise au point 2021 [Autoimmune hepatitis: 2021 update]
G.M. Stamm et al. (Sep 1, 2021)
Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue.
J. Vieira Barbosa et al. (Apr 26, 2021)
Gastroentérologie et hépatologie [Advances in gastroenterology and hepatology 2020]
F. Artru et al. (Jan 13, 2021)
Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis.
P. Filippidis et al. (2021)

next